Increased FoxP3 and PD-L1 in non-pCR tissue from early stage HER2 positive breast cancer patients treated with trastuzumab-pertuzumab based regimens.
Conference Paper
Full Text
Duke Authors
Cited Authors
- Force, JM; Howie, LJ; Abbott, S; Bentley, RC; Marcom, PK; Kimmick, GG; Westbrook, KE; Parks, M; Topping, DL; Broadwater, G; Blackwell, KL; Nair, SK
Published Date
- May 20, 2016
Published In
Volume / Issue
- 34 / 15_suppl
Start / End Page
- 602 - 602
Published By
Electronic International Standard Serial Number (EISSN)
- 1527-7755
International Standard Serial Number (ISSN)
- 0732-183X
Digital Object Identifier (DOI)
- 10.1200/jco.2016.34.15_suppl.602